Also known as: ConcertAI
ConcertAI is a healthcare technology company focused on real-world evidence and generative AI solutions for life sciences and healthcare. It positions its products around data, AI technologies, and clinical/scientific workflows to accelerate insights and outcomes. The company states it is headquartered in Cambridge, Massachusetts.
The global AI in clinical trials market is expected to grow from $2.09 billion currently to $18.62 billion by 2040, driven by enhanced patient recruitment, optimized trial designs, and automation that reduces time and costs in drug development.
Analysts project AI in clinical trials will represent an $8 billion business segment by 2030, generating up to $110 billion per year in value to pharma. Multiple companies unveiled AI-powered platforms at SCOPE 2026 in Orlando.
